To study the effects and mechanisms of insulin-like growth factor I (IGF-I) on brain myelination in ho, the morphology of myelinated axons and the expression of myelin specific protein genes have been examined in transgenic (Tg) The proliferation and differentiation of oligodendrocytes, and the myelination that ensues, are controlled by a number of soluble growth factors and neuronal influences (Chen and De Vries, 1989; Raff, 1989; Hunter and Bottenstin, 1991; Barres and Raff, 1993) . Recent evidence suggests that insulin-like growth factor-I (IGF-I) has an important role in these processes. IGF-I stimulates proliferation and differentiation of oligodendrocyte progenitors in culture (McMorris et al., 1986; McMorris and DuboisDalcq, 1988; Mozell and McMorris, 1991) and promotes the survival of cultured oligodendrocytes (Barres et al., 1992) . Dis-ruption of the IGF-I gene signigicantly decreases oligodendrocyte number in mice (Beck et al., 1995) . Both IGF-I (McMorris, personal communication) and the type I IGF receptor (McMorris et al., 1986; Baron-Van Evercooren et al., 1991; Masters et al., 1991) are expressed by oligodendrocytes and their progenitor cells and by neurons that are located nearby (Bartlett et al., 199 1; Garcia-Segura et al., 1991) . Furthermore, maximal IGF-I expression precedes the peak time of myelin-specific protein gene expression and rapid myelination (Sorg et al., 1987; Campagnoni, 1988; Rotwein et al., 1988; Bach et al., 1991; Bartlett et al., 1991) . The brains of transgenic (Tg) mice that overexpress human IGF-I (hIGF-I) exhibit a marked increase in myelin content (Carson et al., 1993) . To explore the mechanisms of IGF-I's in vivo effects on oligodendrocyte development and on myelination, we have examined the morphology of myelinated axons and the expression of the genes for proteolipid protein (PLP) and myelin basic protein (MBP), the two most abundant myelin-specific proteins, utilizing two Tg mouse models of IGF actions. To evaluate the effects of IGF-I overexpression in brain, new lines of Tg mice were generated using the same hIGF-I fusion gene previously described in studies of IGF-I overexpressing Tg mice (Mathews et al., 1988; Behringer et al., 1990; Carson et al., 1993) . To evaluate a decrease of IGF-I function in brain, we employed Tg mice that express human IGF binding protein-l (hIGFBP-1) ectopically in brain (D'Ercole et al., 1994) . The hIGFBP-1 expressed by these mice (IGFBP-1 Tg mice) is one of the family of IGF binding proteins that modulate the actions of the IGFs (IGF-I and IGF-II) by controlling their serum and tissue concentrations and bioavailability, as well as transporting IGFs from their sites of synthesis (see reviews: Lee et al., 1993; Jones and Clemmons, 1995) . Depending upon its molar concentration, IGFBP-1 can inhibit the actions of the IGFs. In our studies of IGFBP-1 Tg mice (D'Ercole et al., 1994) , we have observed brain growth retardation. As judged by total DNA content, cell number is decreased in these mice. The reduction, however, is not as great as the reduction in brain weight, suggesting that other components of the brain, such as myelin, also are involved.
Using these alternative models of IGF-I overexpression and of decreased IGF bioavailability, we report evidence that IGF-I increases myelination by increasing both the number of myelinated axons and the thickness of myelin sheaths, the latter by mechanisms that involve stimulation of myelin-specific protein gene expression and promotion of oligodendrocyte proliferation and/or survival.
Materials and Methods
Animals.
IGF-I
Tg mice were generated by classical microinjection methodology using the same mouse metallothionionein-I (MT-I) pro- 
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moter-driven hIGF-I fusion gene as previously reported to create the original line of these mice (Mathews et al., 1988) in the Transgenic Core Facility at the University of North Carolina at Chapel Hill. A single line (line 52) of these IGF-I Tg mice was used in this study because its transgene is relatively better expressed in brain than in other organs, as judged by the mRNA and protein levels, and immnostaining intensity (D'Ercole and Ye, unpublished data). As a result, the brains of these Tg mice are overgrown (see Results). However, there is no elevation in serum IGF-I concentrations, nor is there an increase in the body weights in these Tg mice. IGFBP-1 Tg mice, also driven by MT-I promoter, have been described in detail in our previous reports (Dai et al., 1994; D'Ercole et al., 1994) . These mice express IGFBP-1 ectopitally in brain, which results in retardation of brain growth that is apparent by the second week of postnatal life. In this study, we have used the B line exclusively. Both IGF-I and IGFBP-1 Tg mice were bred as heterozygotes in order to obtain non-transgenic littermate mice to serve as normal controls. To generate mice carrying both IGF-I and IGFBP-1 transgenes (IGF-BIGFBP-1 mice), male heterozygous IGF-I Tg mice were bred with female heterozygous IGFBP-1 Tg mice. This mating yielded mice with about 25% of each the following genotypes: nontransgenic normal mice, IGF-I Tg mice, IGFBP-1 Tg mice, and the mice carrying both IGF-I and IGFBP-1 transgens (IGF-l/IGFBP-1). All mice were fed standard laboratory chow. To insure maximum expression of the transgenes, mice were provided drinking water supplemented with 10 mu ZnSO., from 2-3 d after birth and 25 mu ZnSO, from about 25 d of age (Dai et al., 1994) . Their environment was maintained with 12:12 hr (light: dark) cycles at 22°C. The genotypes of mice initially were determined by polymerase chain reaction (PCR) of mouse tail genomic DNA, and further confirmed by Northern or Southern blot analysis for the transgene. All procedures also closely paralleled the amount of total RNA (18s and 28s rRNA) transferred as estimated by methylene blue staining. Histological and histochemical analysis. For myelin staining, 35 d old IGF-I Tg, IGFBP-1 Tg mice, and their littermates (n = 3 for each) were transcardically perfused with 4% paraformaldehyde in phosphatebuffered saline (PBS), pH 7.4. Brains were removed and post-fixed in the same fixative containing 20% sucrose overnight at 4°C. Sagittal sections (25 pm) were cut on a cryostat, mounted onto gelatin-coated slides and stored at -80°C until use. Myelinated fibers were stained using the gold chloride method as described by Schmued (1990) . Briefly, the sections were washed with distilled water and incubated with 0.2% gold chloride (Sigma Chemical, St. Louis, MO) in 0.02 M neutral phosphate buffer with 0.9% NaCl for 2-4 hr at room temperature (RT) or at 42°C. After a brief wash with distilled water, sections were fixed with 2.5% sodium thiosulfate and mounted.
For electron microscopic examination, groups of 3 IGF-I Tg, IGFBP-1 Tg mice and normal littermates at 35 or 68 d of age were perfused and fixed with 2% glutaraldehyde and 2% paraformaldehyde in PBS. The brains were sagittally sliced in -0.5 mm of thickness. The region containing the anterior commissure was blocked out and directionally embedded in epon. Semithin sections (-1 mm) were performed to ensure the location of the anterior commissure. Because of large difference in the morphology and the number of myelinated axons between anterior and posterior parts of mouse anterior commissure, six to nine photographs were randomly taken from each anterior and posterior part of anterior commissure at 7000X, respectively. The number of myelinated axons and the thickness of myelin sheaths were measured on these photographs with the aid of the Image-Pro analysis system. There were no abnormalities in myelin and axon structure observed in either IGF-I or IGFBP-1 Tg mice. The measurement of the thickness of myelin sheaths was taken from the straight and circular fibers, in which both the inner and outer surface of the myelin sheath stood out as sharp, equidistant and parallel lines. The diameter of axons was calculated from the circumference of the inner surface of the myelin sheaths on these fibers. Six to nine thousand axons from the anterior and posterior part of the anterior commissure in each group of mice were counted. Over 1000 and 500 myelinated axons were measured for the thickness of myelin sheaths in the anterior and posterior part of anterior commissure, respectively.
In situ hybridization was performed as described (Zimmermann et al., 1993; Stenvers et al., 1994) except that a digoxigenin-labeled PLP cRNA probe (Dig-riboprobe) and calorimetric detection were employed. After fixation with 4% paraformaldehyde in (PBS), the frozencut sections (10 pm) were treated with 0.2 N HCI, extensively washed with PBS and hybridized with antisense PLP Dig-riboprobe generated from the mouse PLP cDNA-containing plasmid (see above Probes section) using Genius RNA Labeling kit (Boehringer Mannheim, Indianapolis, IN) and T7 RNA polymerase (Stratagene Cloning Systems, La Jolla, CA). The hybridization buffer contained 75% formamide, 10% dextran sulfate, 3 X SSC, 1 X Denhardt's, 50 mM sodium phosphate, pH 7.4, and 0.5 nglpl of the probe. After incubation with the probe for 16-18 hr at 55"C, the sections were washed with 2 X SSC and 1 X SSC at 55°C followed by a wash with 0.5 X SSC for 1 hr at 55°C. The sections then were incubated with nonfat milk, and the sites of PLP mRNA were revealed by incubating with anti-digoxigenin antibody conjugated with alkaline phosphatase (1:250) for 2 hr at RT, and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) with nitroblue tetrazolium (NBT) for 2-3 hr at RT Two sections from each mouse, separated by at least 50 pm to avoid double counting, were counterstained with methylene green, and photographed. The PLP mRNA-positive ohgodendrocytes were counted on the color prints. For each mouse 250-1000 cells (as recognized by nucleus) per area were counted. Liver served as a negative control in which no hybridization signal was observed. Statistics. Statistic comparisons were made using Student's t test.
Results
As demonstrated in previous report, brain growth in IGF-I Tg mice was significantly increased (Mathews et al., 1988; Carson et al., 1993) and that of IGFBP-1 Tg mice decreased (D'Ercole et al., 1994) . At 35 d of age, whole brain weight was increased by 34.19 2 2.76% (mean + SE; IZ = 4; p < 0.001) in IGF-I Tg mice and decreased by 12.20 2 3.70% (n = 6; p < 0.01) in IGFBP-1 Tg mice, compared to their normal littermates (Fig.  1) . To determine the regional alterations in brain growth, brains from 35 d old IGF-I and IGFBP-1 Tg mice, as well as their nontransgenic littermates, were dissected into distinct regions and wet weights determined (Fig. 1) . In IGF-I Tg mice, all brain regions also were increased in weight, with the most affected regions being cerebral cortex, hippocampus, and diencephalon , respectively. The weights of the brainstem and cerebellum in IGFBP-1 mice were more modestly decreased (7.28 + 1.41%, p < 0.05 and 5.95 2 1.57%, p < 0.1, respectively). There was no difference in brain weight between male and female Tg mice of either line or in their normal littermates, and therefore, the data from both sexes were grouped here and in further analyses. Morphologically, the size of most brain structures also was increased in IGF-I Tg mice and decreased in IGFBP-1 Tg mice (Fig. 2) , but no obvious abnormalities were observed. Compared to their normal littermates, the intensity of myelin staining was markedly increased in IGF-I Tg mice and reduced in the IGFBP-1 Tg mice. The increased myelin staining in IGF-I Tg mice was especially notable in layers III to VI of cerebral cortex, anterior commissure (AC), corpus callosum, diencephalon, and brainstem, while in IGFBP-1 Tg mice, the decrease in myelin staining also was apparent in cerebral cortex, AC, corpus callosum, and diencephalon, but not in brainstem and cerebellum (Fig. 2) . High-magnification examination showed that the number of stained fibers was dramatically increased in posterior part of AC (Fig. 2d ) while they were decreased in IGFBP-1 Tg mice (Fig. 2f) . Similar results were observed in other brain regions including frontal cerebral cortex and corpus callosum (data not shown).
To determine whether the changes in myelin staining in these Tg mice were due to changes in the number of myelinated axons or the thickness of myelin sheaths, the AC was examined by electron microscopy. Representative electron micrographs of posterior part of AC from 68 d old mice were given in Figure  2g -i. The AC was chosen because its myelination was apparently altered under light microscopic examination of these mice and because it is rich in myelinated axons that are in same orientation. Six to nine thousand axons from each anterior and posterior part of AC in each group mice were counted, and the number of myelinated axons in both IGF-I and IGFBP-1 Tg mice was expressed as a percentage of the total number of axons. In non-Tg control mice the percentage of myelinated axons in anterior part of the AC was much higher than posterior part, and the number of myelinated axons in both portions increased with age (Table 1) . Similar changes have been observe during development of the AC in rats (Berbel et al., 1994) . In both lines of Tg mice, the number of myelinated axons also increased with age in both anterior and posterior portions of the AC. In IGFBP-1 Tg mice, the percentage of myelinated axons in the anterior part of the AC was decreased by 24% and 9% at 35 and 68 d of age, respectively, compared to non-Tg controls. While in IGF-I Tg mice the percentage of myelinated axons was increased, these changes were not significant. In contrast to the anterior part, the number of myelinated axons in the posterior part of the AC in IGF-I Tg mice was increased by 12% at 35 d of age and further increased by 34% at 68 d of age, while the number of myelinated axons in IGFBP-1 mice also was decreased by 42% and 24% at 35 d at 68 d of age, respectively.
The thickness of myelin sheaths was measured in both anterior and posterior parts of the AC from mice at 68 d of age. The structure of myelin as well as axon appeared normal. Compared to normal control mice (83.04 -t 1. I6 nm, mean 2 SE), the thickness of myelin sheaths in anterior part was significantly increased in IGF-I Tg mice (9 I .76 -C 0.83, p < 0.05), but only modestly decreased in IGFBP-I Tg mice (77.81 + 0.64, p < 0.15, n.s.). The thickness of myelin sheaths in posterior portion was generally less than that in anterior part of the AC. Nevertheless, the thickness of myelin sheaths also was increased in IGF-I Tg mice (77.94 2 0.93 nm, SE, p < 0.001) and decreased in IGFBP-I Tg mice (67.05 + 0.73, p < 0.001) versus normal control (7 I .87 ? 0.84) .
In general, the thickness of myelin sheaths correlates with the diameter of the axons which they ensheath, that is, the larger axons possess thicker myelin sheaths (Hildebrand et al., 1993) . We found that the diameter of myelinated axons was increased in IGF-I Tg mice (592.67 ? 6.21 and 572.44 2 9.40 nm, mean % SE, p < 0.05 and p < 0.001, in anterior and posterior AC, respectively) versus normal control (574.22 2 6.85 and 528.62 + 9. I7 nm), and unchanged in IGFBP-1 Tg mice (567.60 ? 6.23 and 529.72 + 7.48 nm) . To eliminate the possible influence of axon diameter on myelin sheath thickness in these Tg mice, the ratio of myelin sheath thickness to axon diameter was cal- culated and showed an absolute increase in myelin thickness in IGF-I Tg mice (data not shown). To further address this issue, the thickness of myelin sheaths was analyzed in axons of similar diameter (Table 2) . Myelin sheath thickness in IGF-I Tg mice was increased in both anterior and posterior AC regardless of the axon diameter, compared to those of their nontransgenic littermates, while the thickness of myelin sheaths was modestly decreased in IGFBP-I Tg mice.
To evaluate changes in myelin protein gene expression in IGF-I Tg and IGFBP-1 Tg mice, PLP and MBP mRNA abundance was measured. Representative Northern analyses of 35 d old brains are shown in Figures 3 and 4 . In IGF-I Tg mice PLP and MBP mRNA levels were significantly increased in cerebral cortex and hippocampus, but minimally or not increased in diecenphalon, cerebellum and brainstem (Fig. 3) . In IGFBP-1 Tg mice, PLP mRNA levels were significantly reduced in cerebral cortex and hippocampus, but not in cerebellum (Fig. 4) . Next we evaluated the abundance of these mRNAs during development.
During cerebral cortex development in normal mice, both PLP and MBP mRNA levels are very low at 7 d of age, but rapidly increase by I4 d of age and reach a peak at 21 d of age, followed by a gradual decline in the next weeks (Figs. the MBP mRNA levels in IGFBP-I Tg mice were slightly decreased at 21, 28, and 35 d of age, no significant differences were observed, probably due to the large variations among mice.
To determine if the alterations in cerebral cortex PLP mRNA expression were related to changes in the expression of the transgenes, the abundance of IGF-I and IGFBP-I transgene mRNAs also was measured. We found that the changes in myelin protein mRNA levels correlated with both the regional (Figs. 3, 4, 7) and temporal (Fig. 8) 35 d old IGF-I Tg mice, the IGF-I transgene mRNA was most highly expressed in cerebral cortex and hippocampus, where PLP and MBP mRNAs levels exhibited the most markedly elevations (Figs. 3, 7) . The levels of IGF-I transgene mRNA were only IO, 3, and 2% of cerebral cortex levels in diecenphalon, brainstem and cerebellum, respectively (Figs. 3, 7) . During development (Fig. 8, upper panel) , cerebral cortex IGF-I transgene mRNA levels were relatively low at 7 d of age, rapidly increased from I4 to 28 d (I.1 I t 0.13, 2.23 ? 0.29, and 2.91 + 0.54-fold increases at 14, 2 I, and 28 d of age, respectively, compared to the abundance at 7 d; mean + SE; II = 4 or 5) after which the transgene's expression remained stable. The increase in IGF-I transgene mRNA levels paralleled with the changes in PLP mRNA levels.
Like IGF-I transgene mRNA, IGFBP-I transgene mRNA in 35 d old brains was most abundant in cerebral cortex, and was 83 and 75% of cerebral cortex levels in hippocampus and cerebellum, respectively (Figs. 4, 7) . Cerebral cortex IGFBP-I mRNA was very low before 9 d of age, and rapidly increased by I4 and 21 d (2. I9 + 0.35 and 4. I7 t 0.56-fold increases, respectively, compared to its abundance at 9 d of age; mean ? SE; n = 4) (Fig. 8, lower panel) . With the increase of IGFBP-I transgene mRNA, PLP mRNA levels gradually decreased reaching their lowest levels at 28-35 d. The abundance of both transgene mRNAs in hippocampus, cerebellum exhibited a same developing pattern (data not shown). This pattern of IGF-I and IGFBP-I transgene expression is consistent with that of endogenous MT-I mRNA in the mouse brain (Shiraidhi et al., 1991) . If the brain growth retardation and decreased PLP expression in the IGFBP-I Tg mice is the result of inhibition of endogenous IGF-I actions, then IGFBP-I expression would be expected to blunt or ablate the brain overgrowth in IGF-I Tg mice. To test this possibility we bred male IGF-I Tg mice with female IGFBP-1 Tg mice and assessed brain weights and the expression of myelin-specific protein genes at 35 d of age (Table 3 ). The brains of the mice carrying both IGF-I and IGFBP-I transgenes were significantly smaller than those of IGF-I Tg mice, but were larger than those of their normal littermate controls and IGFBP-I Tg mice. All brain regional weights bore the same relationships, except for the cerebellum which did not appear to be affected by IGFBP-I expression. In IGF-I Tg mice cerebral cortex PLP and MBP mRNA abundance was increased about three-and twofold, respectively, and was significantly blunted by IGFBP-I transgene expression (Table 4) .
To determine whether the changes in the expression of PLP and MBP mRNAs in these Tg mice were due to a change in the number of functional oligodendrocytes, we performed in situ hybridization with a probe to PLP mRNA, and the PLP mRNApositive oligodendrocytes in corpus callosum and frontal cerebral cortex (layers 2-6) were counted. As previously reported (Verty and Campagnoni, 1988; Jordan et al., 1989; Shiota et al., 1989) , we found that PLP mRNA is predominantly localized to the cell body of oligodendrocytes.
The total number of labeled oligodendrocytes was significantly increased in IGF-I Tg mice and decreased in IGFBP-I Tg mice (Fig. 9 , Table 5 ). The percentage of PLP mRNA-labeled oligodendrocytes in IGF-I Tg mice was increased by 18.14 2 1.64% (n = 3; 17 < 0.001) and 36.52 + 8.44% (p < 0.01) in corpus callosum and cortex, respectively. The intensity of PLP mRNA labeling also appeared increased in these Tg mice. The percentage of PLP mRNAlabeled oligodendrocytes in IGFBP-I mice was decreased by 4.99 2 1.03% (n = 3; p < 0.05) and 18.36 t 6.39% (p < 0.2, n.s.) in corpus callosum and cortex, respectively.
Discussion
Our data strongly support a role for IGF-I in promoting oligodendrocyte development and stimulating oligodendrocyte function. We demonstrate here that overexpression of IGF-I in brain greatly increases the number of myelinated axons and the thickness of myelin sheaths, associated with increases in the number of oligodendrocytes and the expression of myelin protein genes. These results are consistent with previous report of a marked increase in total brain myelin content in IGF-I Tg mice (Carson et al., 1993) . In contrast to IGF-I Tg mice, the retardation of brain growth in the Tg mice that exhibit ectopic brain expression of IGFBP-I, an inhibitor of IGF action when it is present in molar excess (Hakala-Ala-Pietila et al., 1993; Shambaugh et al., 1993; Verhaeghe et al., 1993; Jones and Clemmons, 1995) , is accompanied by a decrease in the percentage of PLP mRNAexpressing oligodendrocytes and in the abundance of the myelinspecific protein mRNA, and a dramatic decrease in the number of myelinated axons. We also show that increased myelin specific gene expression in IGF-I Tg mice, as well as the brain overgrowth, is blunted by coexpression of the IGFBP-I transgene, strongly indicating that expression of the IGFBP-I in brain inhibits IGF-I actions regardless of whether IGF-I is endogenously derived or is synthesized by the transgene.
During development the increase in the expression of myelin protein gene in cerebral cortex of IGF-I Tg mice correlates regionally and temporally with the increase of IGF-I transgene mRNA levels. The regional brain growth also is closely associated with regional levels of IGF-I transgene mRNA. Furthermore, in the IGFBP-I Tg mice the abundance of myelin protein mRNAs declines in temporal association with the rise in the expression of the IGFBP-I transgene. These data indicate that the changes in myehn protein gene expression, resulting in changes in myelination and brain growth, are dependent upon local transgene expression. The timing of the rise in the expression of both transgenes is the result of their MT-I promoter, because the expression of both transgenes follows the same developmental pattern as does MT-I mRNA in mouse brain (Shiraidhi et al., 199 I ) . The transient decrease in myelin protein gene expression in IGFBP-I Tg mice is consistent with our tindings that the decreased percentage of myelinated axons in the AC of IGFBP-I Tg mice becomes less with age (decreases of 24% vs 9% in anterior part, and 42% vs 24% in posterior part at 35 and 68 d of age, respectively). We speculate that the transiency of IGFBP-I's effects on myelination are related to the decrease in endogenous IGF-I expression with advancing age (Rotwein et al., 1988; Bartlett et al., 1991) . In other words, as IGF-I expression in brain declines and in turn its effects on myelination diminish, the influence of the IGFBP-I transgene is ablated. This also implies that factors other than IGF-I can subserve its role in stimulating myelination.
In contrast to the marked decreases in myelinated axon number in IGFBP-I Tg mice, the increases in myehnated axons in anterior AC of IGF-I Tg mice were minimal. High expression et al., 1993) . Our findings that the myelin protein mRNA abundance in cerebellum is not altered in IGFBP-1 overexpressing mice, and that expression of the IGFBP-1 transgene has little influence on cerebellar size, is consistent with the developmental time of the expression of these MT-I-driven transgenes. Myelination in cerebellum occurs earlier than other forebrain regions (Jacobson, 1963; Caley and Maxwell, 1968; Okado, 1982; Foran and Peterson, 1992 ) and prior to the time of peak expression of IGFBP-I transgene. Although the transgene is expressed well in cerebellum (slightly lower than cerebral cortex), therefore, its effects are not dramatic because of its relatively late expression in cerebellum during development. We used in sirs hybridization with a probe for PLP mRNA to identify oligodendrocytes actively synthesizing this myelin specific protein. IGF-I Tg mice had an increase in the number of oligodendrocytes in the cerebral cortex and corpus callosum, as judged by their percentage representation, while in IGFBP-1 Tg mice oligodendrocyte number was decreased in corpus callosum (the decrease observed in cerebral cortex was not significant). These results suggest that the total number of oligoden- drocytes, as well as their relative number compared to other cell types, is increased in IGF-I Tg and decreased in IGFBP-I Tg mice. These data also suggest that IGF-I plays a role in controlling oligodendrocyte development, proliferation and/or survival. In vitro studies strongly support this conclusion, because IGF-I has been shown to substantially increase oligodendrocyte number both by increasing the proliferation and differentiation of progenitor cells (McMorris et al., 1988) and by increasing survival of oligodendrocytes (Barres et al., 1992) . Carson et al. (1993) , using immunostaining with an antibody to carbonic anhydrase II (CA-II) to identify oligodendrocytes in IGF-I Tg mice, however, did not find an increase in the per- 
